XML 14 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
REVENUES $ 2,889 $ 679
COST OF REVENUES (2,088) (523)
GROSS PROFIT 801 156
RESEARCH AND DEVELOPMENT EXPENSES [1] (5,967) (7,334)
Less - grants 1,338 1,309
RESEARCH AND DEVELOPMENT EXPENSES, NET (4,629) (6,025)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES [1] (2,537) (1,995)
OPERATING LOSS (6,365) (7,864)
FINANCIAL EXPENSES (2,087) (904)
FINANCIAL INCOME 1,625 242
LOSS FROM CHANGE IN FAIR VALUE OF CONVERTIBLE NOTES EMBEDDED DERIVATIVE (52,321)  
FINANCIAL EXPENSES, NET (52,783) (662)
LOSS FROM CONTINUING OPERATIONS (59,148) (8,526)
LOSS FROM DISCONTINUED OPERATIONS 0 (72)
NET LOSS FOR THE PERIOD $ (59,148) $ (8,598)
NET LOSS PER SHARE OF COMMON STOCK - BASIC AND DILUTED    
Loss from continuing operations (in dollars per share) $ (0.48) $ (0.09)
Income from discontinued operations (in dollars per share) 0 (0.00)
Net loss per share of common stock (in dollars per share) $ (0.48) $ (0.09)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE-BASIC AND DILUTED 124,467,602 99,715,625
[1] Includes share-based compensation